Food and Drug Administration to treat type 2 diabetes, weight loss and reduce the risk of cardiovascular disease.The medications are also used for weight loss, delaying gastric (stomach) emptying, decreasing hunger and reducing how much people eat
In parallel, a separate study reported by Reuters linked exercise timing to cardiometabolic risk
Dentro de este mismo grupo la prevalencia de enfermedad heptica grave (ascitis, hipertensin portal, encefalopata o fallo heptico o la presencia de fibrosis portal extensa o cirrosis en la biopsia) fue de 26% a los 2 aos y 50% a los 6 aos 23
(PubMed) Chi X, Zhang R, Shen N, et al
Side effects such as nausea and digestive discomfort are common but may improve with hydration, diet adjustments, and slow dose increases